1-1 of 1
Peter Cutrera, CNMT
Close
Sort by
Journal Articles

Feasibility of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy for Non-Hodgkin’s Lymphoma in a Patient with Chronic Renal Failure.

Stewart M. Spies, MD, Leo I. Gordon, MD, A. Michael Zimmer, PHD, Peter Cutrera, CNMT
Journal: Blood
Blood (2004) 104 (11): 4642.
https://doi.org/10.1182/blood.V104.11.4642.4642
Published: 2004